Read this post for context.
https://hotcopper.com.au/threads/rac-primer.5627186/page-90?post_id=48891722
Then fast-forward to Q4 2021:
How do you think big pharma might react when they stumble on Aussie biotech with pipeline above in context of background in post linked above.
- Assume combination r/r adult AML trial achieves first readout ( positive results with CR around 40%+)
- Assume December 2021 results at ASH conference
- Assume MRD trial underway in USA and/or Australia/Israel
- Assume paediatric AML trial underway in US and Australia and readouts pending
- Assume Breast Cancer trial underway in Australia and/or USA and readouts pending
- Assume some form of FTO clinical program underway ( pending regulatory advisor recommendations )
- Possibly ovarian cancer preclinical study underway or complete
Big pharma are going to want confidence of future FDA approval and future revenues. How confident do you think they will be of future approval and hence revenues in context of info in post linked above?
Also - my last post on timeline
https://hotcopper.com.au/threads/timeline-speculation.5484135/page-32?post_id=45789927#.X7hX6BY8YlQ
Read whole thread:
https://hotcopper.com.au/threads/timeline-speculation.5484135/#.X7hYTBY8YlQ
Read this post for context....
-
- There are more pages in this discussion • 10,107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
-0.140(7.61%) |
Mkt cap ! $289.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.70 | $456.4K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 8662 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |